01/29/2025
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/20/2025
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
7:03 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2025
7:04 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:00 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:01 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:03 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
7:19 PM | BioXcel Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024
4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024
4:20 PM | BioXcel Therapeutics (Subject)
Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
12/17/2024
5:10 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:03 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:04 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:06 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:08 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:21 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:33 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024
2:23 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:00 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
1:10 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:05 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/25/2024
3:06 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024
8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
8:53 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:33 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:40 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:17 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Please take this warning seriously... (Ad) I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days.
In fact, I believe it could begin as soon as March 13th…
Meaning you don’t have much time to prepare. Click here like your financial health depends on it. |
09/17/2024
6:17 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024
6:18 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:19 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:20 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:23 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:42 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:26 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:16 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
2:48 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
1:58 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
12:23 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
9:47 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:41 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
8:22 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4/A | |
06/18/2024
8:24 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:27 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
2:13 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:34 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:09 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:46 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:04 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:21 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
6:00 PM | BioXcel Therapeutics (Issuer)
Bray June (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:00 PM | BioXcel Therapeutics (Issuer)
MILLER MICHAEL PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:01 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:01 PM | BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:02 PM | BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
7:29 PM | BioXcel LLC (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13D/A | |
06/06/2024
7:35 PM | BioXcel Holdings, Inc. (Reporting)
BioXcel LLC (Reporting)
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:30 AM | BioXcel Therapeutics (Filer)
| Form 424B7 | |
05/09/2024
8:05 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:12 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
5:01 AM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
5:03 AM | BioXcel Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
6:10 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
6:01 AM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
04/10/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:31 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A new coin is elbowing its way to the top of the crypto world (Ad) With Donald Trump’s return to the oval office, the war on crypto is over.
The digital currency is not only set to be released from its constraints … it could be about to explode.
Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office. This coin may be Trump’s favorite crypto … |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
1:50 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
1:01 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
12:20 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
12:40 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
3:55 PM | BioXcel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
